Nektar Therapeutics (NASDAQ:NKTR) Adds 2.59% In One Week: What’s Boosting Its Stock?
In recent trading session, Nektar Therapeutics (NASDAQ:NKTR) saw 0.93 million shares changing hands at last check today with its beta currently measuring 0.60. Company’s recent